We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
A summary of the types of scientific advice available at the MHRA, the process for getting advice and the fees involved.
Advice and support for those who are experiencing or feel at risk of sexual violence and abuse.
Government confirms expansion of Advice and Guidance scheme, with more patients now receiving their care closer to home.
Information on cryptosporidium including sources and routes of transmission, symptoms, and general hygiene advice to minimise the spread.
How marketing authorisation holders should inform MHRA of a signal or an ADR to a medicine.
Guidance for people with symptoms of a respiratory infection including COVID-19, or a positive test result for COVID-19.
How to get access to MHRA submissions portals, how to use them, where to go for help.
How to use a before-and-after study to evaluate your digital health product.
Check how the advice and information we give applies to you, what you can expect from us and what to do if you think you have incorrect information.
Guidance on the MHRA’s national assessment procedure for marketing authorisation applications.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).